NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $17.76 +0.05 (+0.28%) (As of 09/27/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Hims & Hers Health Stock (NYSE:HIMS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Key Stats Today's Range$17.03▼$17.9550-Day Range$13.65▼$23.2652-Week Range$5.65▼$25.74Volume5.52 million shsAverage Volume7.69 million shsMarket Capitalization$3.81 billionP/E RatioN/ADividend YieldN/APrice Target$19.86Consensus RatingModerate Buy Company OverviewHims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.Read More… How a $200,000 Mistake Unlocked a $118 Billion Gold Treasure (Ad)The window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Click here now to learn how you can position yourself for potentially massive gains. Hims & Hers Health Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks77th Percentile Overall ScoreHIMS MarketRank™: Hims & Hers Health scored higher than 77% of companies evaluated by MarketBeat, and ranked 272nd out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingHims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.Amount of Analyst CoverageHims & Hers Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth68.18% Earnings GrowthEarnings for Hims & Hers Health are expected to grow by 68.18% in the coming year, from $0.22 to $0.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -1,776.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -1,776.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 11.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Hims & Hers Health's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted16.18% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 5.35%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.18% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 5.35%, indicating that investor sentiment is improving significantly. News and Social Media2.0 / 5News Sentiment0.60 News SentimentHims & Hers Health has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for Hims & Hers Health this week, compared to 11 articles on an average week.Search InterestOnly 72 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.MarketBeat FollowsOnly 10 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,671,277.00 in company stock.Percentage Held by Insiders17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. HIMS Stock News HeadlinesInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells 12,651 Shares of StockSeptember 24, 2024 | insidertrades.comSoleil Boughton Sells 2,339 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockSeptember 18, 2024 | insidertrades.com10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIMES bigger gains than physical gold. That's why I've put together a special presentation on this opportunity...September 28, 2024 | Monument Traders Alliance (Ad)Invest While You Can: Pullbacks on These 3 Stocks Won’t Last Long (HIMS)Three stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't lastSeptember 10, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 188,888 SharesSeptember 8, 2024 | insidertrades.comHims & Hers Health's Options Frenzy: What You Need to KnowSeptember 26 at 6:14 PM | benzinga.comHims & Hers: The Gift That Keeps On GivingSeptember 25 at 10:28 PM | seekingalpha.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 45,767 SharesSeptember 24, 2024 | americanbankingnews.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $8.90 at the beginning of 2024. Since then, HIMS stock has increased by 99.6% and is now trading at $17.76. View the best growth stocks for 2024 here. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings data on Monday, August, 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. The company's revenue was up 51.8% on a year-over-year basis. Who are Hims & Hers Health's major shareholders? Top institutional investors of Hims & Hers Health include Renaissance Technologies LLC (2.81%), Institutional Venture Management XV LLC (1.21%), Dimensional Fund Advisors LP (1.17%) and Marshall Wace LLP (1.03%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Oluyemi Okupe, Michael Chi, Soleil Boughton, Patrick Harrison Carroll, Jules A Maltz, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Lynne Chou O'keefe and Jack Abraham. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/05/2024Today9/28/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryHealthcare Current SymbolNYSE:HIMS CUSIPN/A CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees1,046Year FoundedN/APrice Target and Rating Average Stock Price Target$19.86 High Stock Price Target$25.00 Low Stock Price Target$10.00 Potential Upside/Downside+11.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E Ratio80.73 P/E GrowthN/ANet Income$-23,550,000.00 Net Margins1.70% Pretax Margin1.98% Return on Equity5.25% Return on Assets4.06% Debt Debt-to-Equity RatioN/A Current Ratio2.68 Quick Ratio2.30 Sales & Book Value Annual Sales$872 million Price / Sales4.37 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book11.03Miscellaneous Outstanding Shares214,790,000Free Float176,747,000Market Cap$3.81 billion OptionableOptionable Beta1.05 This page (NYSE:HIMS) was last updated on 9/28/2024 by MarketBeat.com Staff From Our PartnersThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Hims & Hers Health, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.